Disability Buy-Sell Insurance

Disability buy-sell insurance is a type of insurance that helps business owners protect their business in case one of the owners becomes disabled. This insurance is designed to provide funding to buy out a disabled owner's share of the business.  

Here are some key features of disability buy-sell insurance:

  • It is typically purchased by co-owners of a business to protect the business in case one of them becomes disabled.
  • The policy pays out a lump sum benefit to the business owners if one of them becomes disabled and is unable to work.
  • The policy can be structured as either a cross-purchase plan or a redemption plan. In a cross-purchase plan, each owner purchases a policy on the other owners. In a redemption plan, the business itself purchases a policy on each owner.
  • The policy benefit amount is usually based on the value of the disabled owner's share of the business.
  • The policy may have a waiting period before benefits are paid, typically ranging from 30 to 180 days.
  • The policy may also have a benefit period, which is the length of time that benefits will be paid out if the disabled owner remains unable to work.
  • The premium for the policy is generally tax-deductible as a business expense, and the benefits paid out are generally tax-free to the recipient.

Here's an example: Suppose that three co-owners of a business purchase disability buy-sell insurance policies on each other. Each policy has a benefit amount of $500,000, and the policies are structured as a cross-purchase plan. If one of the owners becomes disabled and is unable to work, the other two owners would receive a total benefit of $500,000 to buy out the disabled owner's share of the business. The policy has a waiting period of 90 days and a benefit period of two years.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.